SHENZHEN, China, Nov. 20, 2024 — SLENERGY, a leading provider of smart energy solutions, introduced the iShare-Home Residential Smart Solar System, offering a reliable, efficient, and cost-effective solar power solution. Slenergy's iShare-Home system utilizes an all-inclusive approach, simplifying the process by integrating all components into a single package. This eliminates…
PARIS, Nov. 20, 2024 — Huawei and its key TECH4ALL partners highlighted the expanding role of Huawei’s TECH4ALL initiative in supporting Europe's digital and green transitions at a recent forum. The inaugural day of the Huawei Connect TECH4ALL Forum showcased new and ongoing TECH4ALL projects and their contributions to sustainable…
Stock market symbolTSX: MKP TORONTO, November 19, 2024 – MCAN Mortgage Corporation (“MCAN” or the “Company“) announces that Donald Coulter is stepping down as President, CEO, and director. The Board of Directors (the “Board“) extends its gratitude for Mr. Coulter’s contributions. The Board has appointed Derek Sutherland as MCAN’s Interim…
Building on the earlier November order of 6,500 Avalon A1566 Miners SINGAPORE, Nov. 20, 2024 — Canaan Inc. (NASDAQ: CAN), a leading provider of high-performance computing solutions, today announced that its wholly owned Singapore subsidiary, Canaan Creative Global Pte. Ltd. (“CCG”), has agreed to supply HIVE Digital Technologies Ltd (“HIVE”)…
ODAIA's new Voice Assistant empowers biopharma sales representatives to access AI-driven insights instantly via voice commands on mobile devices. BOSTON, Nov. 20, 2024 — ODAIA today unveiled a voice AI assistant designed for biopharma sales teams. This tool allows representatives to access real-time, AI-powered insights simply by speaking to their…
A new study reveals that home cannabis cultivation is more prevalent and diverse than previously thought, with a strong emphasis on community support. MODESTO, Calif., Nov. 19, 2024 — The image of clandestine home cannabis cultivation is outdated. With 24 states and the District of Columbia now permitting home growing…
MONTREAL, Nov. 20, 2024 – Thryv Therapeutics Inc., a clinical-stage biotechnology company developing new treatments for cardiovascular diseases, announces the appointment of Amy Sehnert, MD, as its Chief Medical Officer (CMO). Dr. Sehnert will oversee clinical development and strategy for Thryv's expanding portfolio of cardiometabolic therapies targeting serum glucocorticoid inducible kinase…
